{"data":{"id":"us-in/ic-25-26-24-18.5","jurisdiction":"us-in","citation":"IC 25-26-24-18.5","heading":"Patient consent","body":"Sec. 18.5. Before reporting patient information to the INSPECT program, an opioid treatment program shall comply with 42 CFR 2.36 and 42 CFR 2.31 in obtaining patient consent.","path":["TITLE 25. PROFESSIONS AND OCCUPATIONS","ARTICLE 26. PHARMACISTS, PHARMACIES, DRUG STORES","Chapter 24. Central Repository for Controlled Substances Data"],"source_url":"https://iga.in.gov/ic/2026/Title_25.html#25-26-24-18.5","current_through":"2026","vintage":"2026","retrieved_at":"2026-10-06T20:43:28Z","sha256":"c157e7d88602ea0f3d26269a704d6f160cfef782732c3c122215ec82b49f939c","source_id":"us-in","stale":false,"prev":"us-in/ic-25-26-24-18","next":"us-in/ic-25-26-24-19"},"notice":"GroundRules: Original legal text. Not legal advice."}